2004•Zhonghua shiyan waike zazhiRequires access

Expression and intervention of hepatocyte growth factors in myocardium and vessel in goldblott hypertensive rats

Gang Hu

Open publisher page 0 citations

Abstract

Objective To observe the effect of valsartan and spironolactone on the expression of hepatocyte growth factors in myocardium and vessel in Goldblott hypertensive rats.Methods Twenty four 6 week SD rats were divided into 4 groups at random:sham operated group,operated group,valsartan group and spironolactone group.Valsartan 30 mg·kg -1 ·d -1 ,spironolactone 20 mg·kg -1 ·d -1 were administered to rats in valsartan group and spironolactone group respectively.The expression of hepatocyte growth factor (HGF) mRNA in myocardium and vessel was determined by RT PCR.Results Levels of HGF mRNA/β actin mRNA in myocardium in valsartan group (1.17±0.08) and spironolactone group (0.85±0.08) were significantly higher than those in operated group (0.57±0.07) ( P 0.01,respectively),but lower than those in sham operated group (1.35±0.09).Levels of HGF mRNA expression in mesenterical arteries of two treatment groups were higher than those in operated group ( P 0.01),but lower than those in sham operated group ( P 0.01).Conclusion AngⅡ AT1 receptor antagonist and mineralocorticoid receptor antagonist prevented myocardial and vascular remodeling,accompanied by a significant increase in myocardial and vascular HGF.Overall,the increase in local HGF expression may play an important role in protection of target organs in Goldblott hypertensive rats.

About this research paper

What this paper is about

Objective To observe the effect of valsartan and spironolactone on the expression of hepatocyte growth factors in myocardium and vessel in Goldblott hypertensive rats.Methods Twenty four 6 week SD rats were divided into 4 groups at random:sham operated group,operated group,valsartan group and spironolactone group.Valsartan 30 mg·kg -1 ·d -1 ,spironolactone 20 mg·kg -1 ·d -1 were administered to rats in valsartan group and spironolactone group respectively.The expression of hepatocyte growth factor (HGF) mRNA in myocardium and vessel was determined by RT PCR.Results Levels of HGF mRNA/β actin mRNA in myocardium in valsartan group (1.17±0.08) and spironolactone group (0.85±0.08) were significantly higher than those in operated group (0.57±0.07) ( P 0.01,respectively),but lower than those in sham operated group (1.35±0.09).Levels of HGF mRNA expression in mesenterical arteries of two treatment groups were higher than those in operated group ( P 0.01),but lower than those in sham operated group ( P 0.01).Conclusion AngⅡ AT1 receptor antagonist and mineralocorticoid receptor antagonist prevented myocardial and vascular remodeling,accompanied by a significant increase in myocardial and vascular HGF.Overall,the increase in local HGF expression may play an important role in protection of target organs in Goldblott hypertensive rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of valsartan and spironolactone on the expression of hepatocyte growth factors in myocardium and vessel in Goldblott hypertensive rats.Methods Twenty four 6 week SD rats were divided into 4 groups at random:sham operated group,operated group,valsartan group and spironolactone group.Valsartan 30 mg·kg -1 ·d -1 ,spironolactone 20 mg·kg -1 ·d -1 were administered to rats in valsartan group and spironolactone group respectively.The expression of hepatocyte growth factor (HGF) mRNA in myocardium and vessel was determined by RT PCR.Results Levels of HGF mRNA/β actin mRNA in myocardium in valsartan group (1.17±0.08) and spironolactone group (0.85±0.08) were significantly higher than those in operated group (0.57±0.07) ( P 0.01,respectively),but lower than those in sham operated group (1.35±0.09).Levels of HGF mRNA expression in mesenterical arteries of two treatment groups were higher than those in operated group ( P 0.01),but lower than those in sham operated group ( P 0.01).Conclusion AngⅡ AT1 receptor antagonist and mineralocorticoid receptor antagonist prevented myocardial and vascular remodeling,accompanied by a significant increase in myocardial and vascular HGF.Overall,the increase in local HGF expression may play an important role in protection of target organs in Goldblott hypertensive rats.

Key concepts: Valsartan, Spironolactone, Internal medicine, Endocrinology, Antagonist, Hepatocyte growth factor, Mineralocorticoid receptor, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and intervention of hepatocyte growth factors in myocardium and vessel in goldblott hypertensive rats — Research Paper | ScholarLens